Biotechs fight fears of ‘antibiotic apocalypse’
Market failure gives little incentive to develop new drugs as antimicrobial resistance grows.
Carb-X and Repair Impact Fund to fund R&D of novel antibiotics. However, Pharma needs to take over later in the development.
Join the AMR Insights Ambassador Network today!
Connect to over 550 AMR professionals and students in 60 countries!